Table 1.
Demographic and Clinical Characteristics of Study Population at Baseline
| With DVT (N=75) | Without DVT (N=399) | Statistic | P | |
|---|---|---|---|---|
| Age, years | 69.83±9.75 | 61.35±11.49 | 5.991 | <0.001 |
| Female, n (%) | 31 (41.3) | 111 (27.8) | 5.495 | 0.019 |
| Length of stay, d | 11 (9,15) | 10 (8,12) | −3.369 | 0.001 |
| Pneumonia, n (%) | 15 (20.0) | 30 (7.5) | 11.446 | 0.001 |
| Smoking | 26 (34.7) | 190 (47.6) | 4.270 | 0.039 |
| Drinking | 28 (37.3) | 157 (39.3) | 0.108 | 0.743 |
| Comorbidities, n (%) | ||||
| Ischemic stroke | 15 (20.0) | 98 (24.6) | 0.723 | 0.395 |
| Hypertension | 43 (57.3) | 241 (60.4) | 0.247 | 0.619 |
| Diabetes | 17 (22.7) | 103 (25.8) | 0.331 | 0.565 |
| Dyslipidemia | 27 (36.0) | 167 (41.9) | 0.895 | 0.344 |
| Coronary artery disease | 3 (4.0) | 30 (7.5) | 1.207 | 0.272 |
| Atrial fibrillation | 17 (22.7) | 37 (9.3) | 11.219 | 0.001 |
| Pharmacological history, n (%) | ||||
| Antihypertensive agents | 37(49.3) | 171(42.9) | 1.075 | 0.300 |
| Hypoglycemic agents | 15(20.0) | 63(15.8) | 0.814 | 0.367 |
| Antiplatelet agents | 7(9.3) | 41(10.3) | 0.062 | 0.804 |
| Stains | 12(16.0) | 82(20.6) | 0.823 | 0.364 |
| Baseline values | ||||
| SBP, mmHg | 150.35±20.35 | 151.73±18.60 | −0.583 | 0.560 |
| DBP, mmHg | 87.00±12.88 | 89.21±10.99 | −1.555 | 0.121 |
| BMI, kg/m2 | 23.90±1.87 | 24.20±2.96 | −0.845 | 0.399 |
| NIHSS, median (IQR) | 10 (6,13) | 7 (5,11) | −3.830 | <0.001 |
| ADL, median (IQR) | 50 (30,80) | 70 (30,80) | −3.033 | 0.002 |
| ONT, min | 177.38±62.53 | 188.71±59.44 | −1.501 | 0.134 |
| DNT, min | 52.83±16.87 | 53.20±25.99 | −0.121 | 0.904 |
| Laboratory parameters | ||||
| Platelet count (*109/L) | 199.40±53.87 | 201.65±49.57 | −0.355 | 0.723 |
| Triglyceride (mmol/L) | 1.32±0.67 | 1.87±1.36 | −3.462 | 0.001 |
| Cholesterol (mmol/L) | 4.83±1.12 | 5.00±0.98 | −1.333 | 0.183 |
| LDL-C (mmol/L) | 2.92±0.87 | 3.04±0.74 | −1.278 | 0.202 |
| HDL-C (mmol/L) | 1.35±0.37 | 1.25±0.30 | 2.540 | 0.011 |
| Glucose (mmol/L) | 8.01±2.90 | 8.09±3.14 | −0.209 | 0.834 |
| PT, s | 11.23±0.79 | 11.04±0.78 | 1.955 | 0.051 |
| APTT, s | 28.85±3.54 | 29.88±3.98 | −2.100 | 0.036 |
| TT, s | 14.59±2.22 | 14.30±2.31 | 0.984 | 0.326 |
| Fibrinogen (g/l) | 3.15±0.68 | 3.11±0.70 | 0.400 | 0.689 |
Abbreviations: DVT, deep vein thrombosis; SD, standard deviation; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; NIHSS, National Institute of Health Stroke Scale; IQR, interquartile range; ADL, activities of daily living; ONT, onset-to-needle time; DNT, door-to-needle time; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; PT, prothrombin time; APTT, activated partial thromboplastin time; TT, thrombin time.